Special Issue "Extracellular Vesicles in Cancer Diagnosis, Progression and Therapy"
Deadline for manuscript submissions: 31 May 2022 | Viewed by 3345
Interests: cancer; Zebrafish; cancer metabolism; telomere maintenance; melanoma; brain tumor; apoptosis; cell-cell interactions; exosomes; cell migration; cell cycle
Interests: extracellular vesicles; RNA-binding proteins; liquid biopsy; cancer; biomarkers; ultrasensitive assays; nanocarriers; high-throughput screening
Extracellular vesicles (EVs), representing an intercellular communication system that is highly enhanced in cancer, continue to attract formidable interest from a wide range of scientists for their tremendous potential to allow discoveries ranging from basic biology to innovative therapeutic approaches.
We are still far away from a full understanding of the roles of EVs in cancer progression, as we have not yet developed their potential as diagnostic or prognostic tools, and we have only glimpsed their value as precision delivery vehicles to transport drugs and non-coding RNAs to target cells.
With this Special Issue, we aim to attract reports that take innovative approaches or express novel views on the multifaceted world of EVs in cancer biology, progression and therapy.
Original papers and review articles that focus on the latest advances in EV studies are welcome. Key areas that will be covered include the following:
- The use of model systems to study the biology of EVs in cancer and exploit them for diagnostic, prognostic and therapeutic approaches;
- The relations between the cell of origin and their targets;
- EVs as a source of biomarkers in liquid biopsy;
- The role of EVs in inflammation and in shaping the tumor microenvironment;
- Specific cargos and their role in recipient cells and cancer progression;
- EV engineering for targeted therapy.
Dr. Maria Caterina Mione
Dr. Vito Giuseppe D'Agostino
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- extracellular vesicles
- model systems
- intercellular communication
- cancer biomarker
- non-coding RNA in cancer
- molecular diagnostics
- liquid biopsies
- molecular engineering
- targeted therapies